|
Gender, Obesity, C-Reactive Protein, and Oxidative Stress Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Gender, Obesity, C-Reactive Protein, and Oxidative Stress conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Gender, Obesity, C-Reactive Protein, and Oxidative Stress Clinical research trials and Gender, Obesity, C-Reactive Protein, and Oxidative Stress healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Gender, Obesity, C-Reactive Protein, and Oxidative Stress. Gender, Obesity, C-Reactive Protein, and Oxidative Stress Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Gender, Obesity, C-Reactive Protein, and Oxidative Stress clinical trial. Participants typically obtain the most effective healthcare available for their Gender, Obesity, C-Reactive Protein, and Oxidative Stress condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "G" Clinical Trials Conditions > Gender, Obesity, C-Reactive Protein, and Oxidative Stress  Gender, Obesity, C-Reactive Protein, and Oxidative Stress
Gender, Obesity, C-Reactive Protein, and Oxidative Stress
For Condition: Cardiovascular Disease
Status: Not yet recruiting
Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ,
Synopsis: This randomized placebo-controlled trial will test whether supplementing with vitamins C and E can lower markers of inflammation and oxidative stress in healthy adults. We will examine whether one antioxidant vitamin is more effective than another, and whether gender or body fat influence the treatment effects. We will also determine whether gender, body fat, or menopausal status are associated with baseline concentrations of inflammation and oxidative stress markers.
Details: Participants will be given 1000 mg vitamin C or 800 IU vitamin E daily for 60 days.
Eligibility:
Study Type: Interventional, Prevention, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion criteria: - Nonsmoker and not passively exposed - Males and females 18 year and older - Able to take vitamin supplements - Able to take acetominophen instead of aspirin or NSAIDs during the study Exclusion criteria: - Pregnancy or lactation - History of ever smoking or passive smoke exposure in the last year - Active liver disease; history of HIV/AIDS, diabetes, kidney stones, hemochromatosis, or autoimmune diseases; heart disease, stroke, or cancer in the last 5 years - User of prescribed anti-inflammatory or lipid-lowering medications, oral contraceptives, hormone replacement therapy, or blood-thinning drugs - User of iron supplements or vitamin E at 600 IU per day or more - Consumption of more than 2 alcoholic beverages per day
Total Enrollment: 400
Location and Contact Information:
University of California, Berkeley School of Public Health
Berkeley, California, 94720-7360
United States
Gladys Block 510-643-7896
Additional Information:
Study ID Numbers: 62378DK;
Study Start Date: April 2004
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00079963
Other Cardiovascular Disease Studies:
1. Technical Development of Cardiovascular Magnetic Resonance Imaging
2. Angiomax in Patients with HIT/HITTS Type II Undergoing CPB
3. Comparing Angiomax to Heparin with Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)
4. Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery
5. Periodontitis and Cardiovascular Events or "PAVE"
Related Studies:
Other Cardiovascular Disease Clinical Trials
Other California Clinical Trials
Other Berkeley Clinical Trials
Gender, Obesity, C-Reactive Protein, and Oxidative Stress
|
|
|
|
|
|
|
|
